GlassScriptPhysician profile
Luke Schlesier
NPI 1194915751
$5,862.79
in general payments reported to CMS, 2019-2025
70 companies · $1,951 in 2025
The $1,951 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $498 · 2022: $600 · 2023: $1,102 · 2024: $1,712 · 2025: $1,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,542 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,542.29 |
| Education | $222.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $457.36 | 2021-2025 | |
| Daiichi Sankyo INC. | $427.80 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Janssen Biotech, INC. | $427.74 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $346.69 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $242.21 | 2022-2025 | Libtayo |
| Eisai INC. | $232.33 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $188.04 | 2022-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Astrazeneca Pharmaceuticals LP | $181.72 | 2023-2025 | Enhertu, Calquence, Lynparza |
| Pfizer INC. | $172.63 | 2021-2025 | |
| Incyte Corporation | $164.08 | 2021-2025 | Monjuvi, Pemazyre, Jakafi |
| Glaxosmithkline, LLC. | $142.12 | 2023-2025 | Jemperli, Zejula, Ojjaara |
| Lilly USA, LLC | $137.23 | 2022-2025 | Verzenio, Jaypirca |
| Seagen INC. | $137.02 | 2021-2023 | Adcetris, Tukysa, Padcev |
| Sobi, INC | $130.08 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.46 | 2022-2025 | Opdivo, Opdualag |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $119.39 | 2022-2025 | |
| Genentech USA, INC. | $109.44 | 2024-2025 | Venclexta, Gazyva, Columvi |
| Taiho Oncology, INC. | $107.71 | 2022-2025 | |
| Gilead Sciences, INC. | $99.99 | 2025 | Trodelvy |
| Ipsen Biopharmaceuticals, INC | $87.02 | 2023-2025 | Onivyde, Somatuline Depot |
| Genmab U.S., INC. | $74.11 | 2023-2024 | Tivdak, Epkinly |
| Servier Pharmaceuticals LLC | $72.89 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $72.42 | 2021-2024 | Xarelto |
| Tersera Therapeutics LLC | $71.08 | 2022-2025 | Zoladex, Xermelo |
| Morphosys, US INC. | $68.32 | 2021-2023 | Monjuvi |
| Emd Serono, INC. | $67.49 | 2023-2025 | Tepmetko, Bavencio |
| Amgen INC. | $65.99 | 2022-2023 | Lumakras |
| Stemline Therapeutics INC. | $65.22 | 2023-2025 | Orserdu |
| Pharmacyclics LLC, An Abbvie Company | $64.10 | 2022-2023 | Imbruvica, Epkinly |
| Dendreon Pharmaceuticals LLC | $62.71 | 2021-2025 | Provenge |
| Celgene Corporation | $60.93 | 2022-2024 | Opdualag, Reblozyl |
| Ge Healthcare | $56.25 | 2021 | |
| Beigene USA, INC. | $54.61 | 2023-2025 | Brukinsa |
| Tempus Ai, INC | $52.99 | 2024 | Xt Cdx |
| Mirati Therapeutics, INC. | $50.16 | 2023-2024 | Krazati |
| Kyowa Kirin, INC. | $47.78 | 2021-2025 | Poteligeo |
| Aveo Pharmaceuticals, INC. | $47.13 | 2022-2024 | |
| Fresenius Kabi USA, LLC | $42.89 | 2023-2024 | Stimufend |
| Beone Medicines USA, INC. | $39.40 | 2025 | Brukinsa |
| Acrotech Biopharma INC. | $38.91 | 2023 | Beleodaq |
| Adaptive Biotechnologies Corporation | $38.50 | 2024-2025 | Clonoseq |
| Karyopharm Therapeutics INC. | $35.97 | 2024-2025 | Xpovio |
| Iovance Biotherapeutics, INC. | $34.08 | 2025 | Amtagvi |
| Springworks Therapeutics, INC. | $33.54 | 2025 | Ogsiveo, Gomekli |
| Genzyme Corporation | $31.92 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $29.99 | 2024 | Sancuso |
| Blueprint Medicines Corporation | $29.71 | 2023-2024 | Ayvakit |
| Myovant Sciences INC. | $28.24 | 2021 | |
| Rigel Pharmaceuticals, INC. | $25.77 | 2024 | Rezlidhia, Tavalisse |
| Heron Therapeutics, INC. | $24.10 | 2023 | Sustol |
| Menarini Silicon Biosystems, INC. | $20.94 | 2025 | Cellsearch |
| Agios Pharmaceuticals, INC. | $20.79 | 2025 | Pyrukynd |
| Novocure INC. | $19.68 | 2025 | Optune Gio |
| Legend Biotech USA INC. | $19.26 | 2025 | Carvykti |
| Azurity Pharmaceuticals, INC. | $19.07 | 2025 | Vivimusta, Danziten |
| Alexion Pharmaceuticals, INC. | $18.78 | 2024 | Ultomiris |
| Celltrion USA INC. | $18.69 | 2024 | Vegzelma |
| Invivyd INC | $18.69 | 2025 | Pemgarda |
| Fennec Pharmaceuticals, INC. | $18.65 | 2025 | Fyarro |
| Sanofi-Aventis U.S. LLC | $17.80 | 2024 | |
| Syndax Pharmaceuticals, INC. | $16.85 | 2025 | Niktimvo |
| Kite Pharma, INC. | $15.09 | 2025 | Yescarta |
| Adc Therapeutics America, INC. | $14.99 | 2024 | |
| Csl Behring | $14.79 | 2025 | Privigen |
| Amneal Pharmaceuticals LLC | $14.68 | 2025 | Alymsys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.59 | 2022 | |
| Pharmaessentia USA Corporation | $14.47 | 2025 | Besremi |
| Apellis Pharmaceuticals, INC. | $14.30 | 2022 | |
| Octapharma USA, INC. | $12.29 | 2022 | |
| Janssen Scientific Affairs, LLC | $11.13 | 2023 | Tecvayli |
Drugs and devices associated with these payments
Enhertu $442Venclexta $269Libtayo $224Lenvima $174Tecvayli $171Darzalex $144Tukysa $138Kisqali $126Talvey $123Ibrance $120Epkinly $114Nubeqa $104Imbruvica $101Trodelvy $99.99Brukinsa $94.01Lonsurf $93.96Inqovi $93.96Zejula $85.16Jemperli $85.16Verzenio $75.06Fabhalta $74.24Ninlaro $74.24Onivyde $73.80Opdivo $69.83Pluvicto $68.90Orserdu $65.22Monjuvi $64.02Piqray $58.63Jaypirca $58.50Ojjaara $56.96Xarelto $56.64Carvykti $55.95Krazati $50.16Vitrakvi $50.02Stivarga $50.02Fruzaqla $49.71Calquence $49.44Opdualag $48.26Gamifant $47.83Injectafer $44.00Adcetris $43.90Stimufend $42.89Tivdak $40.73Xofigo $40.22Lutathera $39.93Optune Gio $39.36Beleodaq $38.91Clonoseq $38.50Xpovio $35.97Rybrevant $35.80Vonjo $34.50Amtagvi $34.08Pemazyre $33.51Zoladex $33.25Poteligeo $33.09Alunbrig $32.27Fotivda $32.24Jakafi $30.89Erleada $30.77Somatuline Depot $30.32Sancuso $29.99Ayvakit $29.71Scemblix $28.35Gazyva $27.29Lunsumio $27.29Columvi $27.29Polivy $27.29Rezlidhia $25.77Tavalisse $25.77Sustol $24.10Elrexfio $23.90Xt Cdx $23.82Cellsearch $20.94Tecentriq $20.92Tecentriq Hybreza $20.92Pyrukynd $20.79Tibsovo $20.44Vivimusta $19.07Danziten $19.07Ultomiris $18.78Pemgarda $18.69Vegzelma $18.69Fyarro $18.65Ogsiveo $18.63Lynparza $18.13Tzield $17.80Synagis $17.69Sarclisa $17.62Reblozyl $17.15Emrelis $16.98Tepmetko $16.92Niktimvo $16.85Voranigo $16.84Elahere $16.76Lumakras $16.76Blenrep $16.71Padcev $16.50Provenge $16.44Iclusig $15.67Yescarta $15.09
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Schlesier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.